Verv Revenue and Competitors

Minsk,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Verv's estimated annual revenue is currently $4.8M per year.(i)
  • Verv's estimated revenue per employee is $116,000

Employee Data

  • Verv has 41 Employees.(i)
  • Verv grew their employee count by -16% last year.

Verv's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$57.6M31824%N/AN/A
#2
$44.6M28623%$25.4MN/A
#3
$5.1M44-6%N/AN/A
#4
$35.1M225-3%$46.9MN/A
#5
$14.5M1005%N/AN/A
#6
$1.3M15-6%N/AN/A
#7
$1.5M170%N/AN/A
#8
$2.9M29-12%N/AN/A
#9
$125.2M6916%N/AN/A
#10
$95.9M529-1%N/AN/A
Add Company

What Is Verv?

Meet Verv – the new Red Rock Apps. It's just made its first appearance with a refreshed concept and a completely new look. Since its launch back in 2013, Verv has become one of the most downloaded Health & Fitness mobile app developers, with over 60 million users worldwide. Its portfolio includes 4 products with more coming this year. Through simple and effective personalized solutions, Verv helps people achieve personal goals, embrace a healthy lifestyle and live a more fulfilling life. Success of the products has been the result of a strong team effort throughout the entire journey of their development. Engineers deliver innovation, designers bring fresh twists to the look and usability, marketers find the best way to position the app knowing it from the inside out – all of this helps create truly great products. Follow the link to learn more: www.verv.com Check out our apps here: iOS: https://itunes.apple.com/us/developer/verv/id583901247 Android: https://play.google.com/store/apps/developer?id=Verv+Inc

keywords:N/A

N/A

Total Funding

41

Number of Employees

$4.8M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Verv News

2022-04-19 - Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks ...

Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks Investment Research to “Sell”. Posted by admin on Apr 22nd, 2022.

2022-04-19 - Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks ...

Verve Therapeutics (NASDAQ:VERV) Downgraded by Zacks Investment Research to “Sell”. Posted by admin on Apr 22nd, 2022.

2022-04-17 - Analysts Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at ...

VERV has been the subject of a number of research analyst reports. Royal Bank of Canada assumed coverage on shares of Verve Therapeutics in...

2022-04-17 - Analysts Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at ...

VERV has been the subject of a number of research analyst reports. Royal Bank of Canada assumed coverage on shares of Verve Therapeutics in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.2M4117%N/A
#2
$8.4M4214%N/A
#3
$4.8M43-2%N/A
#4
$4.5M43-10%N/A
#5
$5.1M440%N/A